New clues found to understanding relapse in breast cancer
A new study by the School of Medicine and others identifies mutations associated with relapse in ER positive breast cancer — knowledge that could lead to better therapies.
Experimental drug shows promise as multiple sclerosis treatment
An experimental drug reduces brain atrophy in people with progressive multiple sclerosis, raising hopes that it also can reduce disability. The School of Medicine is one of 28 clinical sites participating in the study.
Washington People: Robyn Klein
Robyn Klein, MD, PhD, has never bought into the idea that girls and women don’t do science. Not only is Klein — vice provost and associate dean for graduate education for the Division of Biology & Biomedical Sciences — a well-respected expert in neuroimmunology and neuroinfectious diseases, she works hard to promote diversity in science.
Roa memorial service planned Sept. 15
A memorial service in honor of Necita Roa, MD, will take place at 8:30 a.m. Sept. 15 in Graham Chapel on the Danforth Campus. Roa was associate professor emerita of anesthesiology at Washington University School of Medicine in St. Louis. She died in May at age 74.
Jennings named chief of musculoskeletal radiology
Jack W. Jennings, MD, PhD, associate professor of radiology, has been named chief of musculoskeletal radiology for Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis.
Obituary: J. Russell Little, professor emeritus of medicine, 87
J. Russell Little, MD, professor emeritus of medicine, died Aug. 18 in St. Louis following a long illness. He was 87. Little was on the faculty at the School of Medicine from 1964 to 2005.
Alzheimer’s one day may be predicted during eye exam
Using technology similar to what is found in many eye doctors’ offices, School of Medicine researchers have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease.
Natural sugar defends against metabolic syndrome, in mice
New School of Medicine research, in mice, indicates that a natural sugar called trehalose blocks glucose from the liver and activates a gene that boosts insulin sensitivity, reducing the chance of developing diabetes.
Lasers help fight deadly brain tumors
A research team at the School of Medicine has found that laser treatment designed to destroy the deadly brain cancer glioblastoma can add an average of two months to a patient’s life, compared with chemotherapy. The increase is small but meaningful for people who have only months left to live.
Improving health insurance literacy aids Missourians’ ACA enrollment
Research led by the School of Medicine found that community outreach and education are critical for individuals navigating health insurance options available in the Affordable Care Act (ACA) marketplace. Such efforts at the state level may have contributed to a higher enrollment among Missourians in 2018.
View More Stories